Duke Radiation Oncology Annual Report 2025
Message from the Chair
It has been a privilege to serve as chair of Duke Radiation Oncology for the past two decades. Since 2004, we have grown into a globally recognized department, committed to advancing the field, fostering innovation and training the next generation of leaders in oncology. In this issue, we celebrate not only our collective achievements but also mark an important moment of transition. I am pleased to welcome Dr. Erik Sulman as the new chair of our department, effective August 1. His appointment ensures that Duke Radiation Oncology will continue to thrive across all our missions – clinical excellence, cutting-edge research and education.
This report highlights several key milestones, including the 20-year journey with the Medical Physics Graduate Program and the department’s central role in the Duke Center for Brain and Spine Metastasis. You’ll find stories of scientific advancement, like the way basic science interacts with scientific computing in the Lafata Lab, and reflections on leadership and impact. From the introduction of a new treatment system – the Varian Ethos with HyperSight – to a $50 million gift that will bring proton therapy to Duke, we remain at the forefront of innovation.
As always, our mission is rooted in precision, compassion and results – and I’m proud of what we’ve built together.
Thank you to everyone who contributed their time and expertise to this report, especially Miriam Ellis; Wendy Graber; Randy Grimes; Lisa Hall; Crystal Hemminger, BSN, RN; Huth Photography; Nancy Pulliam, BSN, RN, CHPN; Shawn Rocco; J.T. Solomon, CPA, MBA; Heather Spencer, MHA; Michelle Ward; and all those that provided quotes and information. This report was edited and designed by Sarah Brady.
